ontology < open < operation

Facettes :

List of bibliographic references indexed by open

Number of relevant bibliographic references: 12.

Ident.	Authors (with country if any)	Title
000379 (2011)	Robert D. Altman [Canada] ; Anthony E. Lang [Canada] ; Ronald B. Postuma [Canada]	Caffeine in Parkinson's disease: A pilot open‐label, dose‐escalation study
000B61 (2009)	Laura Marsh [États-Unis] ; Kevin Biglan [États-Unis] ; Melissa Gerstenhaber [États-Unis] ; James R. Williams [États-Unis]	Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: A pilot open‐label study
001127 (2007)	Eduardo Tolosa [Espagne] ; Thierry Vander Borght [Belgique] ; Emilio Moreno [Espagne]	Accuracy of DaTSCAN (123I‐ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism: 2‐Year follow‐up of an open‐label study
001248 (2006)	Theresa A. Zesiewicz [États-Unis] ; Kelly L. Sullivan [États-Unis] ; Robert A. Hauser [États-Unis] ; Juan Sanchez-Ramos [États-Unis]	Open‐label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's disease
001249 (2006)	Joseph H. Friedman [États-Unis] ; Robert M. Berman [États-Unis] ; Christopher G. Goetz [États-Unis] ; Stewart A. Factor [États-Unis] ; William G. Ondo [États-Unis] ; Joanne Wojcieszek [États-Unis] ; William H. Carson [États-Unis] ; Ronald N. Marcus [États-Unis]	Open‐label flexible‐dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease
001664 (2004)	Pierre Pollak [France] ; F. Tison [France] ; Olivier Rascol [France] ; A. Destée [France] ; J J Péré [France] ; J M Senard [France] ; F. Durif [France] ; I. Bourdeix [France]	Clozapine in drug induced psychosis in Parkinson’s disease: a randomised, placebo controlled study with open follow up
001A75 (2001)	S. Giménez-Roldán [Espagne] ; D. Mateo [Espagne] ; E. Navarro [Espagne] ; M. M Ginés [Espagne]	Efficacy and safety of clozapine and olanzapine: an open-label study comparing two groups of Parkinson's disease patients with dopaminergic-induced psychosis
001A93 (2001)	Stewart A. Factor [États-Unis] ; Joseph H. Friedman [États-Unis] ; Margaret C. Lannon [États-Unis] ; David Oakes [États-Unis] ; Keith Bourgeois [États-Unis]	Clozapine for the treatment of drug‐induced psychosis in Parkinson's disease: Results of the 12 week open label extension in the PSYCLOPS trial
001E64 (1998)	A. Hansson [Suède] ; M. Holm [Suède] ; P. Blomstro M [Suède] ; R. Johansson [Suède] ; C. Lu Hrs ; J. Brandt ; S. B. Olsson [Suède]	Right atrial free wall conduction velocity and degree of anisotropy in patients with stable sinus rhythm studied during open heart surgery
002129 (1996)	J. Boas [Danemark] ; J. Worm-Petersen [Danemark] ; E. Dupont [Danemark] ; B. Mikkelsen [Danemark] ; L. Wermuth [Danemark]	The levodopa dose‐sparing capacity of pergolide compared with that of bromocriptine in an open‐label, crossover study
002454 (1994)	Letizia Mazzini [Italie] ; Daniela Testa [Italie] ; Carla Balzarini [Italie] ; Gabriele Mora [Italie]	An open-randomized clinical trial of selegiline in amyotrophic lateral sclerosis
002B28 (1982)	Kurt Jellinger [Autriche]	Adjuvant treatment of parkinson's disease with dopamine agonists: Open trial with bromocriptine and CU 32-085

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "open" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "open" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    open
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024